MS
64
3
CCI
30
2
DOV
48
2
LOW
42
14
PHM
44
4
EIX
61
8
KR
50
5
ZION
49
9
LNC
28
3
CLX
65
2
MSI
52
3
HP
44
14
SYF
78
7
PBI
30
-8
RF
44
10
HSY
32
3
INTC
35
4
STT
48
4
PLD
35
5
AIZ
61
5
MS
64
3
CCI
30
2
DOV
48
2
LOW
42
14
PHM
44
4
EIX
61
8
KR
50
5
ZION
49
9
LNC
28
3
CLX
65
2
MSI
52
3
HP
44
14
SYF
78
7
PBI
30
-8
RF
44
10
HSY
32
3
INTC
35
4
STT
48
4
PLD
35
5
AIZ
61
5
Financhill
Back

XTL Biopharmaceuticals 10K Form

Sell
20

XTLB
XTL Biopharmaceuticals

Last Price:
$1.49
Seasonality Move:
19.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive XTLB News And Ratings

See the #1 stock for the next 7 days that we like better than XTLB

XTLB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.50
Price / Book: 2.9

Profitability

EPS (TTM): -0.03130
Net Income (TTM): $-378K
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

XTL Biopharmaceuticals Earnings Forecast

Key XTL Biopharmaceuticals Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 10 years.

XTL Biopharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: XTLB
CUSIP: 98386D
Website: xtlbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XTLB Technical Analysis vs Fundamental Analysis

Sell
20
XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy or a Sell?